The International Myeloma Working Group (IMWG) was formed by the IMF to encourage dialog and collaboration among the world’s leading myeloma experts. IMWG members are divided into workgroups. Researchers in each group work together to examine such important topics as frontline therapy, continuous therapy, the role of transplant, genetic risk stratification, renal impairment, and treatment for elderly patients.
The first IMWG Annual Summit debuted in 2010 in Barcelona and has been followed by Summits held in London (2011), Vienna (2012), Stockholm (2013), in Milan (2014), Vienna (2015), and Copenhagen (2016).
Since its founding, the IMWG has grown in influence and stature, as the result of its many publications in scientific journals and guidelines for myeloma treatment and diagnosis. An IMWG paper co-written by Dr. S. Vincent Rajkumar and IMF Chairman Dr. Brian G.M. Durie on the response criteria for myeloma has become one of the most cited papers in myeloma.
Creating, supporting, and hosting the important work of the IMWG and its members is a critical element of the IMF’s mission to expand myeloma research and to educate myeloma patients around the world.